Capital Market Strategies LLC Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Capital Market Strategies LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% during the first quarter, Holdings Channel reports. The fund owned 1,649 shares of the healthcare conglomerate’s stock after selling 236 shares during the period. Capital Market Strategies LLC’s holdings in UnitedHealth Group were worth $864,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Norges Bank acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $6,375,744,000. Raymond James Financial Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $1,914,740,000. Amundi lifted its holdings in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after buying an additional 2,991,470 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. Finally, Proficio Capital Partners LLC grew its stake in shares of UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Mizuho reduced their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Robert W. Baird reduced their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Hsbc Global Res downgraded UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. Raymond James lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Finally, TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $441.87.

UnitedHealth Group Stock Down 0.0%

UNH opened at $298.11 on Friday. The company has a market cap of $270.42 billion, a PE ratio of 19.23, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm has a 50 day moving average price of $435.12 and a 200 day moving average price of $496.39.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other news, Director Kristen Gil acquired 3,700 shares of the firm’s stock in a transaction on Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.